Other
Zeliha Alicikus
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
3 recruiting
Enrollment Performance
Analytics
N/A
2(100.0%)
2Total
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT07297420Not Yet Recruiting
Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity
Role: lead
NCT07290634Recruiting
Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion
Role: lead
NCT07369921Not ApplicableRecruiting
Pediatric Pilonidal Sinus Surgical Treatment
Role: lead
NCT07222007Recruiting
Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
Role: lead
NCT06663293Not ApplicableCompleted
Comparison of High Flow vs Standard Nasal Cannula in Children With Burns Under Sedoanalgesia
Role: lead
All 5 trials loaded